Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)

NCT00908921 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

391

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: GLIMEPIRIDE

Sponsor

Sanofi